Donald B. Kohn, M.d.

This early-stage study tested a potential one-time treatment for adults with severe sickle cell disease. Doctors collected a patient's own blood stem cells, used a modified virus to insert a healthy gene into them, and then gave them back to the patient. The goal was to see if th…